glucose, (beta-d)-isomer and digoxin
glucose, (beta-d)-isomer has been researched along with digoxin in 12 studies
Research
Studies (12)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 2 (16.67) | 2.80 |
Authors
Authors | Studies |
---|---|
Clark, CA; Esposito, AL; Poirier, WJ | 1 |
NORDSTROEM-OHRBERG, G | 1 |
COVA, N; FERRARI, E | 1 |
BURN, JH; LOURIE, EM; WALKER, JM | 1 |
Chan, K; Jiang, ZH; Liu, L; Liu, ZQ; Wong, YF; Xu, HX; Zhou, H | 1 |
Hu, M; Jiang, ZH; Liu, L; Liu, ZQ | 1 |
Boulton, DW; Chang, M; Griffen, SC; Kasichayanula, S; LaCreta, FP; Liu, X; Shyu, WC | 1 |
Broedl, UC; Macha, S; Pinnetti, S; Rose, P; Schoene, K; Sennewald, R; Woerle, HJ | 1 |
Chen, WM; Shaw, LH; Tsai, TH | 1 |
Bernard, A; Devineni, D; Mamidi, RN; Manitpisitkul, P; Rothenberg, P; Sha, S; Skee, D; Stieltjes, H; Tian, H; Vaccaro, N; Weiner, S | 1 |
Packer, M; Zannad, F | 1 |
Zheng, H | 1 |
Trials
4 trial(s) available for glucose, (beta-d)-isomer and digoxin
Article | Year |
---|---|
The cardiac glycoside digoxin does not alter the activity of human polymorphonuclear leukocytes in vitro.
Topics: Adult; Blood Bactericidal Activity; Chemotaxis, Leukocyte; Digoxin; Humans; Kinetics; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Opsonin Proteins; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1988 |
Lack of pharmacokinetic interactions between dapagliflozin and simvastatin, valsartan, warfarin, or digoxin.
Topics: Adult; Anti-Arrhythmia Agents; Anticholesteremic Agents; Anticoagulants; Antihypertensive Agents; Benzhydryl Compounds; Cross-Over Studies; Diabetes Mellitus, Type 2; Digoxin; Drug Interactions; Female; Glucosides; Humans; Hypoglycemic Agents; Male; Middle Aged; Simvastatin; Sodium-Glucose Transporter 2 Inhibitors; Tetrazoles; Valine; Valsartan; Warfarin | 2012 |
Lack of clinically relevant drug-drug interaction between empagliflozin, a sodium glucose cotransporter 2 inhibitor, and verapamil, ramipril, or digoxin in healthy volunteers.
Topics: Adolescent; Adult; Area Under Curve; Benzhydryl Compounds; Cross-Over Studies; Digoxin; Drug Interactions; Female; Glucosides; Half-Life; Humans; Male; Middle Aged; Ramipril; Reference Values; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Verapamil; Young Adult | 2013 |
Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on the pharmacokinetics of oral contraceptives, warfarin, and digoxin in healthy participants.
Topics: Adult; Anticoagulants; Area Under Curve; Blood Coagulation; Canagliflozin; Cardiotonic Agents; Contraceptives, Oral, Combined; Cross-Over Studies; Digoxin; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Drug Interactions; Ethinyl Estradiol; Female; Glucosides; Half-Life; Healthy Volunteers; Humans; Hypoglycemic Agents; International Normalized Ratio; Levonorgestrel; Male; Metabolic Clearance Rate; Middle Aged; Polypharmacy; Risk Assessment; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Warfarin; Young Adult | 2015 |
Other Studies
8 other study(ies) available for glucose, (beta-d)-isomer and digoxin
Article | Year |
---|---|
EFFECT OF DIGITALIS GLUCOSIDES ON ELECTROCARDIOGRAM AND EXERCISE TEST IN HEALTHY SUBJECTS.
Topics: Adolescent; Biomedical Research; Blood Chemical Analysis; Blood Pressure; Blood Pressure Determination; Digitalis; Digitalis Glycosides; Digitoxin; Digoxin; Electrocardiography; Exercise Test; Glucosides; Healthy Volunteers; Hemoglobins; Lactates; Lanatosides; Metabolism; Pharmacology; Physical Exertion; Respiratory Function Tests | 1964 |
[PRACTICAL CONCEPTS OF DIGITALIS THERAPY. CLINICAL TRIALS WITH A RAPIDLY EXCRETED GLUCOSIDE: DIGOXIN].
Topics: Biomedical Research; Digitalis; Digitalis Glycosides; Digoxin; Geriatrics; Glucosides; Heart Diseases; Humans | 1964 |
The effects of digoxin and ouabain on the heart-lung preparation of the dog.
Topics: Animals; Digoxin; Dogs; Glucosides; Ouabain | 1950 |
The effects of sinomenine on intestinal absorption of paeoniflorin by the everted rat gut sac model.
Topics: Animals; Anti-Inflammatory Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzoates; Bridged-Ring Compounds; Digoxin; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Glucosides; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Intestines; Male; Models, Animal; Monoterpenes; Morphinans; Paeonia; Quinidine; Rats; Rats, Sprague-Dawley; Sinomenium; Time Factors; Verapamil | 2006 |
Mechanisms responsible for poor oral bioavailability of paeoniflorin: Role of intestinal disposition and interactions with sinomenine.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Benzoates; Biological Availability; Biological Transport; Bridged-Ring Compounds; Caco-2 Cells; Cells, Cultured; Chromatography, High Pressure Liquid; Digoxin; Drug Interactions; Glucosides; Humans; Intestinal Absorption; Male; Monoterpenes; Morphinans; Rats; Rats, Sprague-Dawley | 2006 |
Identification of multiple ingredients for a Traditional Chinese Medicine preparation (bu-yang-huan-wu-tang) by liquid chromatography coupled with tandem mass spectrometry.
Topics: 4-Butyrolactone; Benzoates; Bridged-Ring Compounds; Chromatography, High Pressure Liquid; Digoxin; Drugs, Chinese Herbal; Glucosides; Humans; Isoflavones; Limit of Detection; Medicine, Chinese Traditional; Monoterpenes; Reproducibility of Results; Saponins; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triterpenes | 2013 |
Do the Favorable Effects of Digoxin and SGLT2 Inhibitors Really Differ in Patients with Heart Failure and a Reduced Ejection Fraction? A Provocative Side-by-Side Examination of Trial Outcomes.
Topics: Diabetes Mellitus, Type 2; Digoxin; Glucosides; Heart Failure; Humans; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume; Ventricular Dysfunction, Left | 2022 |
Cardiovascular Benefits of Digoxin and Empagliflozin in Patients with Chronic Heart Failure: The DIG Trial Revisited.
Topics: Benzhydryl Compounds; Cardiotonic Agents; Clinical Trials as Topic; Digoxin; Glucosides; Heart Failure; Humans | 2022 |